Segui
Bryn S. Moore
Bryn S. Moore
Laboratory Project Manager, Geisinger Clinic
Email verificata su geisinger.edu
Titolo
Citata da
Citata da
Anno
Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions
R Marullo, E Werner, N Degtyareva, B Moore, G Altavilla, SS Ramalingam, ...
PloS one 8 (11), e81162, 2013
7672013
ALG9 mutation carriers develop kidney and liver cysts
W Besse, AR Chang, JZ Luo, WJ Triffo, BS Moore, A Gulati, DN Hartzel, ...
Journal of the American Society of Nephrology 30 (11), 2091-2102, 2019
1252019
Cilia have high cAMP levels that are inhibited by Sonic Hedgehog-regulated calcium dynamics
BS Moore, AN Stepanchick, PH Tewson, CM Hartle, J Zhang, AM Quinn, ...
Proceedings of the National Academy of Sciences 113 (46), 13069-13074, 2016
1132016
Developmental shifts in fMRI activations during visuospatial relational reasoning
PJ Eslinger, C Blair, JL Wang, B Lipovsky, J Realmuto, D Baker, S Thorne, ...
Brain and cognition 69 (1), 1-10, 2009
962009
Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants
BS Moore, UL Mirshahi, EA Yost, AN Stepanchick, MD Bedrin, AM Styer, ...
PLoS One 9 (4), e93629, 2014
542014
Electronic health record analysis identifies kidney disease as the leading risk factor for hospitalization in confirmed COVID-19 patients
MT Oetjens, JZ Luo, A Chang, JB Leader, DN Hartzel, BS Moore, ...
PloS one 15 (11), e0242182, 2020
392020
T-box3 is a ciliary protein and regulates stability of the Gli3 transcription factor to control digit number
U Emechebe, P Kumar P, JM Rozenberg, B Moore, A Firment, T Mirshahi, ...
Elife 5, e07897, 2016
322016
Exome sequencing of a clinical population for autosomal dominant polycystic kidney disease
AR Chang, BS Moore, JZ Luo, G Sartori, B Fang, S Jacobs, Y Abdalla, ...
Jama 328 (24), 2412-2421, 2022
242022
A conserved mechanism for gating in an ionotropic glutamate receptor
BS Moore, UL Mirshahi, TL Ebersole, T Mirshahi
Journal of Biological Chemistry 288 (26), 18842-18852, 2013
162013
Individuals heterozygous for ALG8 protein-truncating variants are at increased risk of a mild cystic kidney disease
B Apple, G Sartori, B Moore, K Chintam, G Singh, PM Anand, NT Strande, ...
Kidney International 103 (3), 607-615, 2023
112023
Isolation, Characterization, and DNA Binding Kinetics of Three Dirhodium(II,II) Carboxyamidate Complexes: Rh2(μ-L)(HNOCCF3)3 where L= [OOCCH3], [OOCCF3], or [HNOCCF …
SU Dunham, TS Remaley, BS Moore, DL Evans, SU Dunham
Inorganic Chemistry 50 (8), 3458-3463, 2011
102011
Genetic variants help define the role of the MC4R C-terminus in signaling and cell surface stability
BS Moore, T Mirshahi
Scientific Reports 8 (1), 10397, 2018
92018
The phenotypic spectrum of COL4A3 heterozygotes
KV Solanki, Y Hu, BS Moore, V Abedi, V Avula, T Mirshahi, NT Strande, ...
Kidney International Reports 8 (10), 2088-2099, 2023
42023
Risk of Nephrolithiasis in adults heterozygous for SLC34A3 Ser192Leu in an unselected health system cohort
C Nwachukwu, G Singh, B Moore, NT Strande, ID Bucaloiu, AR Chang
Journal of the American Society of Nephrology 34 (11), 1819-1821, 2023
32023
Large scale clinical exome sequencing uncovers the scope and severity of skin disorders associated with MC1R genetic variants
BS Moore, JZ Luo, AN Stepanchick, T Mirshahi
Genetics in Medicine 23 (12), 2386-2393, 2021
22021
DNA damage
BS Moore, LP Morris, PW Doetsch
eLS, 2009
22009
eP077: Atypical polycystic kidney disease in individuals heterozygous for rare ALG8 protein-truncating variants
B Apple, G Sartori, K Chintam, B Moore, W Triffo, N Strande, G Singh, ...
Genetics in Medicine 24 (3), S50-S51, 2022
12022
Framework From a Multidisciplinary Approach for Transitioning Variants of Unknown Significance From Clinical Genetic Testing in Kidney Disease to a Definitive Classification
UL Mirshahi, A Bhan, LE Tholen, B Fang, G Chen, B Moore, A Cook, ...
Kidney International Reports 7 (9), 2047-2058, 2022
2022
Framework for prioritizing variants of unknown significance from clinical genetic testing in kidney disease–utility of multidisciplinary approach to gather evidence of …
UL Mirshahi, A Bhan, LE Tholen, B Fang, G Chen, B Moore, A Cook, ...
medRxiv, 2022.04. 01.22273321, 2022
2022
UTILIZATION OF NGS BROAD-BASED GENETIC TESTING CAN HELP SELECT APPROPRIATE LIVING RELATED KIDNEY DONORS
L Sankar, P Anand, U Mirshahi, B Moore, N Strande, T Mirshahi, K Kalra, ...
AMERICAN JOURNAL OF KIDNEY DISEASES 79 (4), S30-S30, 2022
2022
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20